International Tennis Federation v Varvara Lepchenko

To optimise for archiving, the original image and related documents associated with this article have been removed.

A decision in the case of International Tennis Federation (ITF) against Varvara Lepchenko has been issued by the ITF Independent Panel. 

On 25 August 2021, the ITF issued Ms Lepchenko with a Notice of Charge for the Presence of modafinil acid, a metabolite of modafinil and/or adrafinil, in a Sample collected In-Competition on 12 July 2021.

An Independent Tribunal was appointed to determine this matter, comprised of David Casement QC (Chair), Erika Riedl and Dr Gary O'Driscoll. The Tribunal found that an Anti-Doping Rule Violation (ADRV) had been committed by Ms Lepchenko pursuant to Articles 2.1 and 2.2 of the Tennis Anti-Doping Programme, resulting in a four (4) year period of Ineligibility commencing on 19 August 2021, the date of her Provisional Suspension.

Sport Resolutions is the independent secretariat to the ITF Independent Panel. 

A copy of the full decision can be accessed via the related links tab on the right-hand side. 

You may also like

View All

Grand Slam Track receives emergency funding

Former Olympic champion sprinter Michael Johnson has secured emergency funding for his event Grand Slam Track after it was initially cancelled due to economic concerns

Read More

PGA of America CEO apologies to McIlroy family due to Ryder Cup abuse

The Professional Golfers’ Association of America CEO Derek Sprague will apologise to the family of professional Northern Irish golfer Rory McIlroy for the abuse they faced during the Ryder Cup

Read More

Paris 2024 Olympic Games had modest economic impact

According to France’s Court of Auditors, the Paris 2024 Olympic Games only produced a modest economic impact

Read More